Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Open-Angle Glaucoma (OAG) Market Size from 2025 to 2034?
In recent times, the market size for open-angle glaucoma (oag) has experienced significant growth. It is projected to increase from $6.13 billion in 2024 to $6.53 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.5%. This growth during the historic period can be credited to the rising cases of glaucoma among older age groups, heightened awareness regarding early diagnosis of eye disorders, increasing healthcare spending, government-driven vision care initiatives, and the worldwide expansion of ophthalmology practices.
Predictions indicate a robust expansion for the open-angle glaucoma (oag) market in the upcoming years, with an anticipated growth to$8.36 billion in 2029″, escalating at a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this progression in the forecast range includes a burgeoning demand for combination treatments, a pivot towards personalised medication, enhanced reimbursement schemes for glaucoma procedures, a surge in ocular diseases induced by lifestyle changes, and an escalating requirement for non-invasive diagnostic techniques. Notable trends forecasted for this period encompass a growing inclination towards AI in glaucoma diagnostics, a transition towards outpatient glaucoma surgery, increased utilisation of sustained-release glaucoma implants, a rise in implementing wearable technology for measuring intraocular pressure, and an intensified focus on sustainable practices in the production of medical devices.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp
What Are the Core Growth Drivers Propelling the Open-Angle Glaucoma (OAG) Market Forward?
The increasing understanding of eye diseases is anticipated to drive the expansion of the open-angle glaucoma (OAG) market in the future. Eye ailments refer to medical situations affecting the vision or functioning of the eyes, and can range from minor issues like dry eyes to severe conditions like glaucoma and macular degeneration. The rise in these medical situations stems from aging populations, extended screen times, a surge in diabetes cases, environmental contamination, and lifestyle practices that affect eyes. Open-angle glaucoma (OAG), a main source of blindness particularly in older adults, stresses the essential need for regular eye check-ups, early detection, and timely intervention to avert irreversible loss of sight. For example, as reported by the Royal National Institute of Blind People (RNIB), a UK-based charity for sight loss, the UK recorded over eight million eye care outpatient visits in 2021/22, marking it as the most sought-after specialty. Furthermore, the number of people with vision loss, presently over two million, is forecasted to jump to over four million by 2050. As a result, the escalating knowledge of eye ailments is propelling the growth of the open-angle glaucoma (OAG) market.
What Segment Types Define the Open-Angle Glaucoma (OAG) Market Structure?
The open-angle glaucoma (oag)market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type
2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class
3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma; Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma; Congenital Glaucoma; Secondary Glaucoma
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Open-Angle Glaucoma (OAG) Market?
North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theOpen-Angle Glaucoma (OAG) Industry Evolution?
The prominent firms in the open-angle glaucoma (OAG) market are focusing on the advancement of cutting-edge solutions such as minimally invasive glaucoma devices (MIGDs). These novel solutions are aimed to offer better and lesser invasive substitutes for managing primary open-angle glaucoma, thereby mitigating the overreliance on conventional methods. A minimally invasive glaucoma device (MIGD) is an assortment of medical implants and practices developed to reduce the intraocular pressure in patients suffering from glaucoma, achieved via minimal incisions and least disturbance to the ocular tissues. For example, iSTAR Medical, a medical tech company headquartered in Belgium, introduced MINIject in the Netherlands in December 2023. This integrated therapy for primary open-angle glaucoma employs an exclusive porous STAR material to improve fluid drainage and lessen intraocular pressure (IOP). By lessening dependability on traditional treatments, MINIject brings a significant leap forward in the treatment of glaucoma, presenting a safer and more effective control solution for this primary contributor to irreversible blindness.
View the full report here:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
What Is the Definition of the Open-Angle Glaucoma (OAG) Market?
Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model